S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:INVO

INVO Bioscience (INVO) Stock Price, News & Analysis

$1.08
-0.02 (-1.82%)
(As of 03/28/2024 ET)
Today's Range
$1.08
$1.17
50-Day Range
$0.85
$1.26
52-Week Range
$0.50
$13.52
Volume
14,363 shs
Average Volume
20,667 shs
Market Capitalization
$2.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
INVO stock logo

About INVO Bioscience Stock (NASDAQ:INVO)

INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. INVO Bioscience, Inc. was founded in 2007 and is based in Sarasota, Florida.

INVO Stock Price History

INVO Stock News Headlines

INVO Bioscience (NASDAQ:INVO) Stock Price Down 8.8%
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
INVO Bioscience Inc INVO
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
INVO Reports Record Third Quarter 2023 Financial Results
What's Going On With INVO BioScience Stock?
BHAT and INVO among pre-market losers
See More Headlines
Receive INVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for INVO Bioscience and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/15/2021
Today
3/29/2024
Next Earnings (Estimated)
4/15/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:INVO
Fax
N/A
Employees
15
Year Founded
N/A

Profitability

Net Income
$-10,890,000.00
Net Margins
-459.42%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$820,000.00
Book Value
($1.61) per share

Miscellaneous

Free Float
2,388,000
Market Cap
$2.67 million
Optionable
No Data
Beta
1.45
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Steven M. Shum (Age 53)
    CEO & Director
    Comp: $260k
  • Mr. Andrea GorenMr. Andrea Goren (Age 57)
    Chief Financial Officer
    Comp: $215k
  • Mr. Michael Jos. Campbell (Age 66)
    COO & VP of Business Development
    Comp: $220k
  • Mr. Bojan Mitrovic Ph.D.
    Director of Sales US
  • Mr. Robert Joseph Bowdring Jr. (Age 66)
    Treasurer & Secretary
  • Ms. Terah Krigsvold
    Controller

INVO Stock Analysis - Frequently Asked Questions

How have INVO shares performed in 2024?

INVO Bioscience's stock was trading at $1.35 at the beginning of 2024. Since then, INVO stock has decreased by 20.0% and is now trading at $1.08.
View the best growth stocks for 2024 here
.

When is INVO Bioscience's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, April 15th 2024.
View our INVO earnings forecast
.

How were INVO Bioscience's earnings last quarter?

INVO Bioscience, Inc. (NASDAQ:INVO) announced its earnings results on Monday, November, 15th. The company reported ($4.80) earnings per share for the quarter, missing the consensus estimate of ($4.00) by $0.80. The business earned $0.22 million during the quarter, compared to the consensus estimate of $0.25 million. INVO Bioscience had a negative trailing twelve-month return on equity of 7,630.09% and a negative net margin of 459.42%. During the same quarter in the previous year, the business posted ($7.20) earnings per share.

When did INVO Bioscience's stock split?

INVO Bioscience's stock reverse split before market open on Thursday, July 27th 2023. The 1-20 reverse split was announced on Thursday, July 27th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, July 27th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Who are INVO Bioscience's major shareholders?

INVO Bioscience's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (2.19%), Vanguard Group Inc. (2.18%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Andrea Goren, Awm Investment Company, Inc, Matthew K Szot, Michael Jos Campbell and Steve Shum.
View institutional ownership trends
.

How do I buy shares of INVO Bioscience?

Shares of INVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:INVO) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners